Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: ppublish

Résumé

Influenza, COVID-19, tetanus, pertussis and hepatitis B pose increased risk for pregnant women and infants and could be mitigated by maternal immunization. In India Tetanus-diphtheria (Td) and COVID-19 vaccines are recommended during pregnancy, while influenza and tetanus-acellular pertussis-diphtheria (Tdap) vaccines are not. We conducted a multicenter study from November 2021 to June 2022 among pregnant women ( Vaccinations during pregnancy protect mothers and babies from lethal infections from tetanus, influenza, COVID-19, pertussis, and hepatitis B. In India all pregnant women get tetanus (Td) vaccines, and during the pandemic, pregnant women got COVID-19 vaccines as part of the government program. We conducted a study among pregnant women attending three public hospitals in West Bengal, India, during the COVID-19 pandemic to understand the factors that influence women’s decisions to get vaccinated during pregnancy. We found that most pregnant women had gotten Td (88.4%) and COVID-19 (93%) vaccines; however, the uptake was low for influenza (0.6%), pertussis (0%), and hepatitis B vaccines (6%) which are all not available in government programs. Though the majority (92%) of women had not heard about influenza vaccines, once they learnt about them, 93% said they would get vaccinated and even pay for it. Vaccination at flexible times and their doctor’s advice were important in their decisions to get vaccinated. Our research builds the case to include influenza, pertussis, and hepatitis B vaccines in programs for pregnant women.

Autres résumés

Type: plain-language-summary (eng)
Vaccinations during pregnancy protect mothers and babies from lethal infections from tetanus, influenza, COVID-19, pertussis, and hepatitis B. In India all pregnant women get tetanus (Td) vaccines, and during the pandemic, pregnant women got COVID-19 vaccines as part of the government program. We conducted a study among pregnant women attending three public hospitals in West Bengal, India, during the COVID-19 pandemic to understand the factors that influence women’s decisions to get vaccinated during pregnancy. We found that most pregnant women had gotten Td (88.4%) and COVID-19 (93%) vaccines; however, the uptake was low for influenza (0.6%), pertussis (0%), and hepatitis B vaccines (6%) which are all not available in government programs. Though the majority (92%) of women had not heard about influenza vaccines, once they learnt about them, 93% said they would get vaccinated and even pay for it. Vaccination at flexible times and their doctor’s advice were important in their decisions to get vaccinated. Our research builds the case to include influenza, pertussis, and hepatitis B vaccines in programs for pregnant women.

Identifiants

pubmed: 39082142
doi: 10.1080/21645515.2024.2383030
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0
Diphtheria-Tetanus-acellular Pertussis Vaccines 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2383030

Auteurs

Tila Khan (T)

School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.

Ranjan Saurav Das (RS)

School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.

Mithu Jana (M)

School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.

Sangeeta Das Bhattacharya (SD)

School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.

Sayantan Halder (S)

School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.

Sabyasachi Ray (S)

Department of Obstetrics & Gynaecology, Midnapore Medical College and Hospital, Midnapore, India.

Parthasarathi Satpathi (P)

Department of Microbiology, Midnapore Medical College and Hospital, Midnapore, India.

Tarapada Ghosh (T)

Department of Paediatrics and Neonatology, Midnapore Medical College and Hospital, Midnapore, India.

Krishnendu Mukherjee (K)

Antenatal Clinic, Kharagpur Sub Divisional Hospital, Kharagpur, India.

Shubhendu Pal Choudhury (SP)

Antenatal Clinic & Baby Clinic, South Eastern Railway Hospital, South Eastern Railway, Kharagpur, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH